Drug of abuse such as opiates have been shown to exert immunomodulatory effects and thereby serve as a cofactor in the progression of HIV-1 infection. Opiate and HIV target areas in brain such as basal ganglia and cortex that are enriched in 5 opioid receptors. Previous studies have shown that opiates act synergistically with HIV proteins (Tat and gp120) to potentiate HIV- related neurotoxicity, which ultimately leads to progression of NeuroAIDS. Currently, there is no treatment available to alleviate the synergistic effects of opiates and HIV, especially due to impenetrability of therapeutic molecules across the blood brain barrier (BBB). Therefore development of a drug delivery system containing an 5 opioid antagonist, a neuroprotective agent and ART that can cross BBB may have significant therapeutic advantage for treatment of opiate addiction and NeuroAIDS. In recent years, nanoparticle based delivery systems have shown promising approach for drug targeting to the brain. In the present proposal, we will develop a unique magnetically guided nanocarrier bound to CTOP (BBB impenetrable In Specific Aim 1 (b) the developed formulation will be tested in vitro for its ability to transmigrate across BBB. Finally, in Specific Aim 2 we will evaluate the in vivo efficacy of the developed nanocarrier in an HIVE SCID morphine mouse model. The efficacy parameters will be antiretroviral efficacy, neuropathology, neuroprotection and morphine related behaviors in mouse. Based on our preliminary study which shows that AZTTP binds significantly to nanoparticles and it inhibits viral replication in PBMCs, we propose that the developed nanocarrier will provide a potential therapeutic approach to treat opiate addiction and NeuroAIDS.

Public Health Relevance

This application has significant relevance to the purpose of the PAS-08-186, drug of abuse such as opiates have been shown to exert immunomodulatory effects and thereby serve as a cofactor in the progression of HIV-1 infection. Currently, there is no treatment available to alleviate the synergistic neurotoxicity of opiates and HIV, especially due to impenetrability of therapeutic molecules across the BBB. This project will evaluate a novel magnetically guided nanocarrier drug delivery system for simultaneous targeting of CTOP, BDNF and AZTTP across the BBB, thereby reduce opiate addiction and also NeuroAIDS in HIV infected subjects who are opiate users.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA027049-05
Application #
8468152
Study Section
Special Emphasis Panel (ZRG1-AARR-H (02))
Program Officer
Khalsa, Jagjitsingh H
Project Start
2009-08-01
Project End
2014-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
5
Fiscal Year
2013
Total Cost
$677,521
Indirect Cost
$168,315
Name
Florida International University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
071298814
City
Miami
State
FL
Country
United States
Zip Code
33199
Vashist, Arti; Kaushik, Ajeet; Vashist, Atul et al. (2016) Recent trends on hydrogel based drug delivery systems for infectious diseases. Biomater Sci 4:1535-1553
Atluri, Venkata Subba Rao; Pilakka-Kanthikeel, Sudheesh; Garcia, Gabriella et al. (2016) Effect of Cocaine on HIV Infection and Inflammasome Gene Expression Profile in HIV Infected Macrophages. Sci Rep 6:27864
Raymond, A D; Diaz, P; Chevelon, S et al. (2016) Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides. J Neurovirol 22:129-39
Kaushik, Ajeet; Jayant, Rahul Dev; Tiwari, Sneham et al. (2016) Nano-biosensors to detect beta-amyloid for Alzheimer's disease management. Biosens Bioelectron 80:273-87
Nair, Madhavan; Jayant, Rahul Dev; Kaushik, Ajeet et al. (2016) Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS. Adv Drug Deliv Rev 103:202-17
Jayant, R D; Nair, M (2016) Role of Biosensing Technology for NeuroAIDS Management. J Biosens Bioelectron 7:
Kaushik, Ajeet; Vabbina, Phani Kiran; Atluri, Venkata et al. (2016) Electrochemical monitoring-on-chip (E-MoC) of HIV-infection in presence of cocaine and therapeutics. Biosens Bioelectron 86:426-31
Jayant, Rahul Dev; Sosa, Daniela; Kaushik, Ajeet et al. (2016) Current status of non-viral gene therapy for CNS disorders. Expert Opin Drug Deliv 13:1433-45
Kaushik, Ajeet; Tiwari, Sneham; Dev Jayant, Rahul et al. (2016) Towards detection and diagnosis of Ebola virus disease at point-of-care. Biosens Bioelectron 75:254-72
Samikkannu, Thangavel; Atluri, Venkata S R; Nair, Madhavan P N (2016) HIV and Cocaine Impact Glial Metabolism: Energy Sensor AMP-activated protein kinase Role in Mitochondrial Biogenesis and Epigenetic Remodeling. Sci Rep 6:31784

Showing the most recent 10 out of 48 publications